Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP003350priorityCriticalpatent/ECSP003350A/en
Publication of ECSP003350ApublicationCriticalpatent/ECSP003350A/en
Una composiciòn farmacèutica, la cual comprende (A) formoterol o una sal farmnacèuticamente aceptable del mismo, o un solvato de formoterol de dicha sal, y (B) propionato de flucticasona, adecuada para utilizarse en el tratamiento de enfermedades inflamatorias u obtructivas de las vias aèreas.A pharmaceutical composition, which comprises (A) formoterol or a pharmaceutically acceptable salt thereof, or a formoterol solvate of said salt, and (B) fluctuicason propionate, suitable for use in the treatment of inflammatory or obstructive pathway diseases aerial.
ECSP0033502000-02-152000-02-15
COMBINATIONS OF A BETA AGONIST- 2- AND A STEROID
ECSP003350A
(en)
INHALABLE PHARMACEUTICAL COMBINATION CONTAINING (A) FORMOTEROL, OR A SALT, OR A SOLVATE OF IT OR THE SALT AND (B) MOMETASONE FUROATE; PHARMACEUTICAL CASE THAT UNDERSTANDS IT; AND ITS USE IN THE THERAPY OF AN INFLAMMATORY OR OBSTRUCTIVE DISEASE OF THE V
PHARMACEUTICAL COMBINATION THAT INCLUDES EDOTECARINE OR A PHARMACEUTICALLY ACCEPTABLE SALT AND DOCETAXEL OR CAPACITABINE, THERAPEUTIC KIT, USEFUL FOR THE TREATMENT OF CANCER.
Liposomal composition containing antihistamine and corticosteroids and its use for the preparation of a medicament for therapeutic therapeutic therapeutic